MedTrace Logo

PRedictive Accuracy of Initial Stone Burden Evaluation.

NCT04746378 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-04-12

No results posted yet for this study

Summary

This study is intended to be a prospective registry of patients undergoing any kind of stone treatment that have a pre-operative CT available. This imaging will be used to measure the stone burden in three different ways: in a single dimension (cumulative stone diameter), in two dimensions (surface area) and in three dimensions (volume).The primary purpose is to identify what way of measuring stone burden is most predictive of outcomes after stone treatment such as stone free status, operative time and complications.

Conditions

  • Urolithiasis
  • Ureterolithiasis
  • Nephrolithiasis

Interventions

DIAGNOSTIC_TEST

Computed Tomography, CSD

Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software

DIAGNOSTIC_TEST

Computed Tomography, SA

Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software

DIAGNOSTIC_TEST

Computed Tomography, 3D

Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software

Sponsors & Collaborators

  • EAU Young Academic Urologists Urolithiasis and Endourology Working Group

    collaborator UNKNOWN

  • European Association of Urology Section of Uro-Technology

    collaborator UNKNOWN

  • Endourological Society TOWER Research Team

    collaborator UNKNOWN

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Thomas Tailly, MD · University Hospital, Ghent

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2028-01-01
Completion
2028-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04746378 on ClinicalTrials.gov